PathWhiz ID | Pathway | Meta Data |
---|---|---|
PW127970View Pathway |
drug action
Paroxetine Mechanism of Action Action Pathway (New)Homo sapiens
Paroxetine is a selective serotonin reuptake inhibitor. It is used to manage major depressive disorder, panic disorder, OCD, social phobia, generalized anxiety disorder, the vasomotor symptoms of menopause, and premenstrual dysphoric disorder.
Paroxetine selectively binds to the sodium dependent serotonin transporter (SERT) and blocks the recycling of serotonin from the synapse. As serotonin accumulates it enhances the serotonergic function of the 5-hydroxytryptamine 1A receptor leading to decreased anxiety and depressive moods. Lower serotonin concentrations in a depressed brain induces the upregulation of serotonergic receptors therefore by increasing the concentration of serotonin in the synapse, paroxetine in turn induces down regulation of the former upregulated serotonin receptors thereby restoring receptor concentration. Paroxetine has demonstrated a stronger inhibitory effect on serotonin reuptake than other members of the same drug class, including Citalopram, Fluoxetine, and Fluvoxamine.
|
Creator: Omolola Created On: June 26, 2023 at 10:10 Last Updated: June 26, 2023 at 10:10 |
PW128109View Pathway |
drug action
Paroxetine Mechanism of Action Action Pathway NewHomo sapiens
Paroxetine is a selective serotonin reuptake inhibitor. It is used to manage major depressive disorder, panic disorder, OCD, social phobia, generalized anxiety disorder, the vasomotor symptoms of menopause, and premenstrual dysphoric disorder.
Paroxetine selectively binds to the sodium dependent serotonin transporter (SERT) and blocks the recycling of serotonin from the synapse. As serotonin accumulates it enhances the serotonergic function of the 5-hydroxytryptamine 1A receptor leading to decreased anxiety and depressive moods. Lower serotonin concentrations in a depressed brain induces the upregulation of serotonergic receptors therefore by increasing the concentration of serotonin in the synapse, paroxetine in turn induces down regulation of the former upregulated serotonin receptors thereby restoring receptor concentration. Paroxetine has demonstrated a stronger inhibitory effect on serotonin reuptake than other members of the same drug class, including Citalopram, Fluoxetine, and Fluvoxamine.
|
Creator: Omolola Created On: July 18, 2023 at 14:26 Last Updated: July 18, 2023 at 14:26 |
PW176397View Pathway |
Paroxetine Predicted Metabolism PathwayHomo sapiens
Metabolites of Paroxetine are predicted with biotransformer.
|
Creator: Omolola Created On: December 07, 2023 at 16:47 Last Updated: December 07, 2023 at 16:47 |
PW146578View Pathway |
drug action
Parthenolide Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 18:33 Last Updated: October 07, 2023 at 18:33 |
PW145731View Pathway |
drug action
Pasireotide Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 16:30 Last Updated: October 07, 2023 at 16:30 |
PW146718View Pathway |
drug action
Patent Blue Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 18:52 Last Updated: October 07, 2023 at 18:52 |
PW176475View Pathway |
Patent Blue Predicted Metabolism PathwayHomo sapiens
Metabolites of Patent Blue are predicted with biotransformer.
|
Creator: Omolola Created On: December 12, 2023 at 16:06 Last Updated: December 12, 2023 at 16:06 |
PW122450View Pathway |
physiological
PathwayHomo sapiens
|
Creator: Guest: Anonymous Created On: April 15, 2019 at 08:17 Last Updated: April 15, 2019 at 08:17 |
PW124347View Pathway |
disease
Pathway in cancerHomo sapiens
|
Creator: Guest: Anonymous Created On: November 19, 2020 at 11:38 Last Updated: November 19, 2020 at 11:38 |
PW000974View Pathway |
PathWhiz Pt.2 - Video Learning Tutorials (Skeleton)Homo sapiens
|
Creator: Guest: Anonymous Created On: July 15, 2015 at 10:00 Last Updated: July 15, 2015 at 10:00 |